I agree that this site is using cookies. You can find further informations here.
X
Fossler, Michael J
77  results:
Search for persons X
?
1

Commentary on Improving the Efficiency of Clinical Pharmaco..:

Fossler, Michael J.
Clinical Pharmacology in Drug Development.  12 (2023)  8 - p. 775-778 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Budget impact and pharmacy costs with targeted use of olice..:

Simpson, Kit N ; Fossler, Michael J ; Wase, Linda..
Expert Review of Pharmacoeconomics & Outcomes Research.  22 (2022)  4 - p. 671-681 , 2022
Link: https://doi.org/10.1080/..
 
?
3

The effect of TRV027 on coagulation in COVID‐19: A pilot ra..:

Robbins, Alexander J. ; Che Bakri, Nur Amalina ; Toke‐Bjolgerud, Edward...
British Journal of Clinical Pharmacology.  89 (2022)  4 - p. 1495-1501 , 2022
Link: https://doi.org/10.1111/..
 
?
4

Oliceridine Exhibits Improved Tolerability Compared to Morp..:

Hammer, Gregory B. ; Khanna, Ashish K. ; Michalsky, Cathy...
Pain and Therapy.  10 (2021)  2 - p. 1343-1353 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Two‐Part Phase 1 Multiple‐Ascending‐Dose Study to Evaluate ..:

Ramos, Kimberly A. ; James, Ian E. ; Skobieranda, Franck...
Clinical Pharmacology in Drug Development.  11 (2021)  1 - p. 51-62 , 2021
Link: https://doi.org/10.1002/..
 
?
6

Oliceridine is Associated with Reduced Risk of Vomiting and..:

Beard, Timothy L. ; Michalsky, Cathy ; Candiotti, Keith A....
Pain and Therapy.  10 (2020)  1 - p. 401-413 , 2020
Link: https://doi.org/10.1007/..
 
?
7

Evaluating the Incidence of Opioid-Induced Respiratory Depr..:

Ayad, Sabry ; Demitrack, Mark A. ; Burt, David A....
Clinical Drug Investigation.  40 (2020)  8 - p. 755-764 , 2020
Link: https://doi.org/10.1007/..
 
?
8

Functionally Selective Inhibition of the Oxytocin Receptor ..:

Blanks, Andrew M ; Quenby, Siobhan ; Fossler, Michael J.
Endocrinology.  161 (2020)  2 - p. , 2020
Link: https://doi.org/10.1210/..
 
?
9

A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Si..:

Fossler, Michael J. ; Schmith, Virginia ; Greene, Stephen A....
CNS Drugs.  34 (2020)  8 - p. 853-865 , 2020
Link: https://doi.org/10.1007/..
 
?
10

The Influence of Renal or Hepatic Impairment on the Pharmac..:

Nafziger, Anne N. ; Arscott, Kelly A. ; Cochrane, Kristina...
Clinical Pharmacology in Drug Development.  9 (2019)  5 - p. 639-650 , 2019
Link: https://doi.org/10.1002/..
 
?
11

A Randomized, Placebo‐Controlled Trial to Assess the Effect..:

Olson, Eric J. ; Mahar, Kelly M. ; Haws, Thomas F....
Clinical Pharmacology in Drug Development.  8 (2019)  7 - p. 871-883 , 2019
Link: https://doi.org/10.1002/..
 
?
12

Population Pharmacokinetics of Pemetrexed in Adult Non–Smal..:

Srinivasan, Meenakshi ; Chaturvedula, Ayyappa ; Fossler, Michael J....
The Journal of Clinical Pharmacology.  59 (2019)  9 - p. 1216-1224 , 2019
Link: https://doi.org/10.1002/..
 
?
13

Assessment of Demographic and Socio-Behavioral Factors on A..:

Mallayasamy, Surulivelrajan ; Chaturvedula, Ayyappa ; Fossler, Michael J....
Frontiers in Pharmacology.  10 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
14

A First‐in‐Human Clinical Study With TRV734, an Orally Bioa..:

James, Ian E. ; Skobieranda, Franck ; Soergel, David G....
Clinical Pharmacology in Drug Development.  9 (2019)  2 - p. 256-266 , 2019
Link: https://doi.org/10.1002/..
 
?
15

The Potential Role of the J‐Tpeak Interval in Proarrhythmic..:

Vicente, Jose ; Strauss, David G. ; Upreti, Vijay V....
The Journal of Clinical Pharmacology.  59 (2019)  7 - p. 909-914 , 2019
Link: https://doi.org/10.1002/..
 
1-15